1
Paul Glue, David L Cutler, Melton B Affrime: Polyethylene glycol modified interferon therapy. Schering Corporation, Jaye P McLaughlin, June 1, 1999: US05908621 (91 worldwide citation)

A method comprising administering a PEG.sub.12000 -IFN alpha conjugate to an individual afflicted with a viral infection susceptible of treatment with interferon alpha, preferably chronic hepatitis C, is disclosed.


2

3